Evidence map›Paper›PMID 39128984›Full record

ArticleBMC cancer2024

β2-microglobulin induced apoptosis of tumor cells via the ERK signaling pathway by directly interacting with HFE in HER2-overexpressing breast cancer.

Kesheng Li, Dandan Chai, Shiyang Ren, Xiaowen Lian, Xiaoling Shi, Yang Xu, Lie Bao, Suisheng Yang, Yurong Liang, Xiaoqin Li and 1 more

Abstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kesheng Li *Department of Medicine Biotechnology, Gansu Provincial Academic Institute for Medical Research, 2 East Xiaoxihu Street, Lanzhou, China.
Dandan Chai *Department of Medicine Biotechnology, Gansu Provincial Academic Institute for Medical Research, 2 East Xiaoxihu Street, Lanzhou, China.
Shiyang RenBioscience College, Lanzhou University, Lanzhou, China.
Xiaowen LianDepartment of Medicine Biotechnology, Gansu Provincial Academic Institute for Medical Research, 2 East Xiaoxihu Street, Lanzhou, China.
Xiaoling ShiDepartment of Medicine Biotechnology, Gansu Provincial Academic Institute for Medical Research, 2 East Xiaoxihu Street, Lanzhou, China.
Yang XuDepartment of Medicine Biotechnology, Gansu Provincial Academic Institute for Medical Research, 2 East Xiaoxihu Street, Lanzhou, China.
Lie BaoBioscience College, Lanzhou University, Lanzhou, China.
Suisheng YangDepartment of Breast Surgery, Gansu Provincial Cancer Hospital, Lanzhou, China.
Yurong LiangDepartment of Breast Surgery, Gansu Provincial Cancer Hospital, Lanzhou, China.
Xiaoqin LiDepartment of Pathology, Gansu Provincial Cancer Hospital, Lanzhou, China.
Huifen DuDepartment of Medicine Biotechnology, Gansu Provincial Academic Institute for Medical Research, 2 East Xiaoxihu Street, Lanzhou, China. shwjshzhx@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur previous study demonstrated that β2-microglobulin (β2M) promoted ER

methodsThe interaction between β2M and HFE was confirmed by co-immunoprecipitation, mass spectrometry, yeast two-hybrid screening, and His pull-down. The knockdown and overexpression of β2M or HFE were performed in MDA-MB-453 cells, and ERK signaling pathway was subsequently analyzed via western blotting. Apoptotic cells were detected using flow cytometer. β2M, HFE, and p-ERK1/2 were examined in tumor and paired adjacent tissues via immunohistochemistry.

resultsHFE was found to be an interacting protein of β2M in ER

conclusionsβ2M induced apoptosis of tumor cells via activation of the ERK signal pathway by directly interacting with HFE in HER2-overexpressing breast cancer.

Indexed as

Apoptosisbeta 2-MicroglobulinBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesHemochromatosis ProteinMAP Kinase Signaling SystemCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansProtein BindingB2M protein, humanbeta 2-MicroglobulinERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesHemochromatosis ProteinHFE protein, humanApoptosisERK signaling pathwayHER2-overexpressing breast cancerProtein–protein interactionβ2M

Identifiers

PMID39128984
PMCPMC11318297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.